Program PDF Monday, March 30, 2020 Updated: 02-14-20
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Surgical Advances in Heart and Lung Transplantation
Anesthesiology Clin N Am 22 (2004) 789–807 Surgical advances in heart and lung transplantation Eric E. Roselli, MD*, Nicholas G. Smedira, MD Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Desk F25, 9500 Euclid Avenue, Cleveland, OH 44195, USA The first heart transplants were performed in dogs by Alexis Carrel and Charles Guthrie in 1905, but it was not until the 1950s that attempts at human orthotopic heart transplant were reported. Several obstacles, including a clear definition of brain death, adequate organ preservation, control of rejection, and an easily reproducible method of implantation, slowed progress. Eventually, the first successful human to human orthotopic heart transplant was performed by Christian Barnard in South Africa in 1967 [1]. Poor healing of bronchial anastomoses hindered early progress in lung transplantation, first reported in 1963 [2]. The first successful transplant of heart and both lungs was accomplished at Stanford University School of Medicine (Stanford, CA) in 1981 [3]. The introduction of cyclosporine to immunosuppres- sion protocols, with lower doses of steroids, led to the first successful isolated lung transplant, performed at Toronto General Hospital in 1983 [4]. Since these early successes at thoracic transplantation, great progress has been made in the care of patients with end-stage heart and lung disease. Although only minor changes have occurred in surgical technique for heart and lung transplantation, the greatest changes have been in liberalizing donor criteria to expand the donor pool. This article focuses on more recent surgical advances in donor selection and management, procurement and implantation, and the impact these advances have had on patient outcome. -
Bundled PCI Services in a Non-Hospital Cath Lab: Environmental Scan/Annotated Bibliography
Bundled PCI Services in a Non-Hospital Cath Lab: Environmental Scan/Annotated Bibliography The research questions guiding the environmental scan and the search strategy are described in detail in the attached appendix. The components of the annotated bibliography below (with links and citations to sources) are grouped into topic areas with main points relevant to the proposal review outlined below. BRIEF DESCRIPTION OF THE PROPOSAL The “Bundled PCI Services in a Non-Hospital Cath Lab” proposal aims to reduce costs of Percutaneous Coronary Interventions (PCIs) by giving Medicare patients the option to have the procedure performed in a non-hospital outpatient cardiac catheterization (cath) lab. Clearwater Cardiovascular Consultants, the submitting organization, proposes Bundled PCI services to allow qualified non-hospital cath labs the ability to perform PCIs, beginning with CCC’s own established cath lab as a limited scale test case to develop appropriate criteria, with expansion to at least two additional cath labs in the next year. SUBMITTING ORGANIZATION Clearwater Cardiovascular Consultants Clearwater Cardiovascular Consultants (CCC) is a cardiovascular medicine group founded in 1975, located in Clearwater, Florida, and comprised of 20+ physicians. Prior to 2016, CCC physicians provided PCI services at a hospital outpatient cardiac cath lab owned by Morton Plant Hospital (MPH), located near the emergency room/hospital outpatient lab. On January 1, 2016, CCC acquired this cath lab from MPH, retaining the same staff. http://www.ccicheart.com/ https://baycare.org/mph Bundled PCI Services in a Non-Hospital Cath Lab, June 2018 1 CURRENT ISSUES AND CONCERNS WITH MEDICARE PAYMENT FOR PCI CCC proposes an approach that will reduce spending for Anchor PCI procedures by an estimated $1,285 for a single vessel PCI and $3,105 for a multi-vessel PCI by performing PCIs in more cost-effective facilities as appropriate. -
Event Winners
Meet History -- NCAA Division I Outdoor Championships Event Winners as of 6/17/2017 4:40:39 PM Men's 100m/100yd Dash 100 Meters 100 Meters 1992 Olapade ADENIKEN SR 22y 292d 10.09 (2.0) +0.09 2017 Christian COLEMAN JR 21y 95.7653 10.04 (-2.1) +0.08 UTEP {3} Austin, Texas Tennessee {6} Eugene, Ore. 1991 Frank FREDERICKS SR 23y 243d 10.03w (5.3) +0.00 2016 Jarrion LAWSON SR 22y 36.7652 10.22 (-2.3) +0.01 BYU Eugene, Ore. Arkansas Eugene, Ore. 1990 Leroy BURRELL SR 23y 102d 9.94w (2.2) +0.25 2015 Andre DE GRASSE JR 20y 215d 9.75w (2.7) +0.13 Houston {4} Durham, N.C. Southern California {8} Eugene, Ore. 1989 Raymond STEWART** SR 24y 78d 9.97w (2.4) +0.12 2014 Trayvon BROMELL FR 18y 339d 9.97 (1.8) +0.05 TCU {2} Provo, Utah Baylor WJR, AJR Eugene, Ore. 1988 Joe DELOACH JR 20y 366d 10.03 (0.4) +0.07 2013 Charles SILMON SR 21y 339d 9.89w (3.2) +0.02 Houston {3} Eugene, Ore. TCU {3} Eugene, Ore. 1987 Raymond STEWART SO 22y 80d 10.14 (0.8) +0.07 2012 Andrew RILEY SR 23y 276d 10.28 (-2.3) +0.00 TCU Baton Rouge, La. Illinois {5} Des Moines, Iowa 1986 Lee MCRAE SO 20y 136d 10.11 (1.4) +0.03 2011 Ngoni MAKUSHA SR 24y 92d 9.89 (1.3) +0.08 Pittsburgh Indianapolis, Ind. Florida State {3} Des Moines, Iowa 1985 Terry SCOTT JR 20y 344d 10.02w (2.9) +0.02 2010 Jeff DEMPS SO 20y 155d 9.96w (2.5) +0.13 Tennessee {3} Austin, Texas Florida {2} Eugene, Ore. -
Health Facilities and Services Review Board
STATE OF ILLINOIS HEALTH FACILITIES AND SERVICES REVIEW BOARD 525 WEST JEFFERSON ST. • SPRINGFIELD, ILLINOIS 62761 •(217) 782-3516 FAX: (217) 785-4111 DOCKET NO: BOARD MEETING: PROJECT NO: September 14, 2021 21-016 PROJECT COST: H-04 FACILITY NAME: CITY: Original: $170,520,604 NorthShore Glenbrook Hospital Glenview TYPE OF PROJECT: Substantive HSA: VII PROJECT DESCRIPTION: The Applicant [NorthShore University HealthSystem] is asking the State Board approve establishment of an open-heart surgery category of service, the addition of 8 cardiac cath labs, and the addition of 6 surgery rooms at Glenbrook Hospital in Glenview, Illinois. The cost of the project is $170,520,604. The expected completion date is December 31, 2024. The purpose of the Illinois Health Facilities Planning Act is to establish a procedure (1) which requires a person establishing, constructing or modifying a health care facility, as herein defined, to have the qualifications, background, character and financial resources to adequately provide a proper service for the community; (2) that promotes the orderly and economic development of health care facilities in the State of Illinois that avoids unnecessary duplication of such facilities; and (3) that promotes planning for and development of health care facilities needed for comprehensive health care especially in areas where the health planning process has identified unmet needs. Cost containment and support for safety net services must continue to be central tenets of the Certificate of Need process. (20 ILCS 3960/2) The Certificate of Need process required under this Act is designed to restrain rising health care costs by preventing unnecessary construction or modification of health care facilities. -
Stent Technology Takes Two Steps Forward
Inside This Issue Heart and Vascular Update Hybrid operating room, provides information to PRESORTED HEART and VASCULAR healthcare providers on the latest FIRST CLASS MAIL a regional first in cardiovascular medicine and surgery U.S. POSTAGE at The Christ Hospital. PAID Stent technology takes CINCINNATI, OH Heart and Vascular Update PERMIT #5489 two steps forward Editorial Board 2139 Auburn Avenue | Cincinnati, Ohio 45219 Stent technology Dean J. Kereiakes, MD, FDA advisory panel: Medical Director SPRING 2013 The Christ Hospital Heart and Vascular Center Update MitraClip could serve as takes two steps forward Carl and Edyth Lindner Research Center an alternative treatment Ian Sarembock, MD, Executive Medical Director for reducing mitral Resorbable Absorb scaffold and flexible Absorb takes bioabsorbability to next level The Christ Hospital Heart and Vascular Service Line regurgitation For the past two decades, incremental improvements in stent Mike Keating Synergy stent expected to improve technology have improved outcomes for hundreds of thousands of President and CEO outcomes in coronary artery disease people with coronary artery blockages. These devices have evolved Michael W. Schwebler from short, bare-metal mesh tubes that could be deployed only The Carl and Eydth Lindner Research Center at The Christ Hospital is Executive Director in the largest coronary vessels to a variety of thinner, longer stents The Christ Hospital Heart and Vascular Service Line leading two major clinical trials that will significantly advance stent coated with -
Diagnosis and Treatment of Myocarditides
DIAGNOSIS AND TREATMENT OF MYOCARDITIDES Clinical guidelines Task force for preparing the text of recommendations Chairperson: Professor S.N. Tereshchenko (Moscow), Task force members: I.V. Zhirov (MD, Moscow), Professor V.P. Masenko (MD, Moscow), O.Yu. Narusov (Ph.D., Moscow), S.N. Nasonova (Ph.D., Moscow), Professor A.N. Samko (MD, Moscow), O.V. Stukalova (Ph.D., Moscow) and M.A. Shariya (MD, Moscow) Expert Committee: Professor Arutyunov G.P. (Moscow), Professor Moiseev S.V. (Moscow), Professor Vasyuk Yu.A. (Moscow), Professor Garganeeva A.A. (Tomsk), Professor Glezer M.G. (Moscow region), Professor Tkacheva O.N. (Moscow) Professor Shevchenko A.O. (Moscow), Professor Govorin A.V. (Chita), Professor Azizov V.A. (Azerbaijan), Professor Mirrahimov E.M. (Kyrgyzstan), Professor Abdullaev T.A. (Uzbekistan), Ph.D. Panfale E.M. (Moldova), MD Sudzhaeva O.A. (Belarus) Moscow, 2019 TABLE OF CONTENTS Page INTRODUCTION ............................................................................................................. 4 Evidence Base for Diagnosis and Treatment of Myocarditides…………….……6 I. MYOCARDITIDES CLASSIFICATION ................................................................... 5 1. Fulminant myocarditis. .................................................................................................... 6 2. Acute myocarditis. ........................................................................................................... 6 3. Chronic active myocarditis. ............................................................................................ -
Program PDF Saturday, March 28, 2020 Updated: 02-14-20
Program PDF Saturday, March 28, 2020 Updated: 02-14-20 Special ‐ Events and Meetings Congenital Heart Disease ‐ Scientific Session #5002 Session #602 Fellowship Administrators in Cardiovascular Education and ACHD Cases That Stumped Me Training Meeting, Day 2 Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. Saturday, March 28, 2020, 7:30 a.m. ‐ 5:30 p.m. Room S105b Marriott Marquis Chicago, Great Lakes Ballroom A CME Hours: 1.5 / CNE Hours: CME Hours: / CNE Hours: Co‐Chair: C. Huie Lin 7:30 a.m. Co‐Chair: Karen K. Stout Fellowship Administrators in Cardiovascular Education and Training Meeting, Day 2 8:00 a.m. LTGA, Severe AV Valve Regurgitation, Moderately Reduced EF, And Atrial Acute and Stable Ischemic Heart Disease ‐ Scientific Arrhythmia Session #601 Elizabeth Grier Treating Patients With STEMI: What They Didn't Teach You in Dallas, TX Fellowship! Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. 8:05 a.m. Room S505a ARS Questions (Pre‐Panel Discussion) CME Hours: 1.5 / CNE Hours: Elizabeth Grier Dallas, TX Co‐Chair: Frederick G. Kushner Co‐Chair: Alexandra J. Lansky 8:07 a.m. Panelist: Alvaro Avezum Panel Discussion: LTGA With AVVR And Reduced EF Panelist: William W. O'Neill Panelist: Jennifer Tremmel Panelist: Jonathan Nathan Menachem Panelist: Joseph A. Dearani 8:00 a.m. Panelist: Michelle Gurvitz Case of a Young Women With STEMI Panelist: David Bradley Jasjit Bhinder Valhalla, NY 8:27 a.m. ARS Questions (Post‐Panel Discussion) 8:05 a.m. Elizabeth Grier Young Women With STEMI: Something Doesn't Make Sense... -
Signal Processing Techniques for Phonocardiogram De-Noising and Analysis
-3C).1 CBME CeaEe for Bionedio¡l Bnginocdng Adelaide Univenity Signal Processing Techniques for Phonocardiogram De-noising and Analysis by Sheila R. Messer 8.S., Urriversity of the Pacific, Stockton, California, IJSA Thesis submitted for the degree of Master of Engineering Science ADELAIDE U N IVERSITY AUSTRALIA Adelaide University Adelaide, South Australia Department of Electrical and Electronic Faculty of Engineering, Computer and Mathematical Sciences July 2001 Contents Abstract vi Declaration vll Acknowledgement vul Publications lx List of Figures IX List of Tables xlx Glossary xxii I Introduction I 1.1 Introduction 2 t.2 Brief Description of the Heart 4 1.3 Heart Sounds 7 1.3.1 The First Heart Sound 8 1.3.2 The Second Heart Sound . 8 1.3.3 The Third and Fourth Heart Sounds I I.4 Electrical Activity of the Heart I 1.5 Literature Review 11 1.5.1 Time-Flequency and Time-Scale Decomposition Based De-noising 11 I CO]VTE]VTS I.5.2 Other De-noising Methods t4 1.5.3 Time-Flequency and Time-Scale Analysis . 15 t.5.4 Classification and Feature Extraction 18 1.6 Scope of Thesis and Justification of Research 23 2 Equipment and Data Acquisition 26 2.1 Introduction 26 2.2 History of Phonocardiography and Auscultation 26 2.2.L Limitations of the Hurnan Ear 26 2.2.2 Development of the Art of Auscultation and the Stethoscope 28 2.2.2.L From the Acoustic Stethoscope to the Electronic Stethoscope 29 2.2.3 The Introduction of Phonocardiography 30 2.2.4 Some Modern Phonocardiography Systems .32 2.3 Signal (ECG/PCG) Acquisition Process .34 2.3.1 Overview of the PCG-ECG System .34 2.3.2 Recording the PCG 34 2.3.2.I Pick-up devices 34 2.3.2.2 Areas of the Chest for PCG Recordings 37 2.3.2.2.I Left Ventricle Area (LVA) 37 2.3.2.2.2 Right Ventricular Area (RVA) 38 oaooe r^fr /T ce a.!,a.2.{ !v¡u Ãurlo¡^+-;^l ¡rr!o^-^^ \!/ ^^\r¡ r/ 2.3.2.2.4 Right Atrial Area (RAA) 38 2.3.2.2.5 Aortic Area (AA) 38 2.3.2.2.6 Pulmonary Area (PA) 39 ll CO]VTE]VTS 2.3.2.3 The Recording Process . -
October 23 2016
Saint Rafka Maronite Catholics of the East in the Upstate! 1215 S. Highway 14, Greer, SC 29650 864.469.9119 www.saintrafka,net [email protected] Saint Rafka Maronite Church is a Catholic Parish of the Antiochene Syriac Maronite Church, Eparchy of Saint Maron of Brooklyn, NY, Most Rev. Gregory John Mansour, Bishop, 109 Remsen Street, Brooklyn, NY, 11201, 718.237.9913. [email protected] Rev. Bartholomew Leon, Administrator, [email protected] October 23, 2016 Rev. Christopher Henderson, Retired, [email protected] Pastor’s Advisory Council Ramiz Askar, Marlene Saad Secretary Richard Sleiman, Chairman Paul Sleiman, Linda Wickett, Jack Yacu 6th Sunday of Holy Cross Finance Committee The themes of being vigilant, alert, and George Azan, Joseph Chebir Chairman prepared - from the Gospel of the Apostle Tony Sleiman, Paula Howard Matthew - continue to be our main accent for this holy season of the Cross. To these lessons, Administration Richard, Wickett, Financial Secretary the Parable of the Talents and the reading Nemr Farhat, Volunteer from Galatians, add a new perspective on the Administrative Assistant to the Pastor quality of the waiting for the Lord. The delay of the Master’s coming is seen according to our scriptures as opportunity to do good for God in the world; to help + increase the riches and the joys of his goodness in his creation. In today’s parable we are invited to be good stewards in God’s vineyards: and to double up the goods that he Continued next page 6th Holy Cross ★Calendar has already bestowed upon us. This parable-theme is October accentuated in Saint Paul’s letter as he says: “Let us 22, 4 PM, Vigil Liturgy not grow tired of doing good; for in due time we shall 23, 11 AM, Divine Liturgy reap our harvest.” 7 PM, Divine Liturgy 26, 7 PM, Divine Liturgy These scriptures therefore contribute to our 29, 4 PM, Vigil Liturgy understanding of the kind of waiting we are to 30, 11 AM, Divine Liturgy engage-in while awaiting our Lord’s coming. -
May 2, 2020 Live the Ucf Creed
UNIVERSITY OF CENTRAL FLORIDA COMMENCEMENT MAY 2, 2020 LIVE THE UCF CREED INTEGRITY I will practice and defend academic and personal honesty. SCHOLARSHIP I will cherish and honor learning as a fundamental purpose of my membership in the UCF community. COMMUNITY I will promote an open and supportive campus environment by respecting the rights and contributions of every individual. CREATIVITY I will use my talents to enrich the human experience. EXCELLENCE I will strive toward the highest standards of performance in any endeavor I undertake. UNIVERSITY OF CENTRAL FLORIDA | COMMENCEMENT | MAY 2, 2020 About the University of Central Florida The University of Central Florida is a bold, public research institution that is regularly ranked among the nation’s top 20 most innovative universities by U.S. News & World Report. With more than 69,500 students, UCF is one of the largest universities in the United States and is ranked as one of the best educational values in the nation by Forbes and Kiplinger. The university benefits from a diverse faculty and staff who create a welcoming environment and opportunities for all students to grow, learn, and succeed. A Foundation for Success UCF and its 13 colleges offer more than 220 degrees at UCF’s main campus, hospitality campus, health sciences campus, online and through multiple regional locations. The 1,415-acre main campus is 13 miles east of downtown Orlando and adjacent to one of the top research parks in the nation. Other campuses are located throughout Central Florida and include a fully accredited College of Medicine at Lake Nona. -
Frater, Robert
Oral History Interview with Robert Frater Cardiothoracic Surgeon St. Jude’s Medical Center FDA Oral History Program Final Edited Transcript May 2003 Table of Contents Oral History Abstract ...................................................................................................................... 2 Keywords ........................................................................................................................................ 2 Citation Instructions ........................................................................................................................ 2 Interviewer Biography ..................................................................................................................... 3 FDA Oral History Program Mission Statement .............................................................................. 3 Statement on Editing Practices ....................................................................................................... 3 Index ............................................................................................................................................... 4 Interview Transcript ........................................................................................................................ 5 Robert Frater Oral History 1 Oral History Abstract This interview was conducted in an effort to collect background information on the development of cardiothoracic surgery and heart valve design and surgical implantation. Dr. Frater was a pioneer in the development -
Diagnostic Yield and Safety Profile of Endomyocardial Biopsy in the Non
REC Interv Cardiol. 2019;1(2):99-107 Original article Diagnostic yield and safety profile of endomyocardial biopsy in the non-transplant setting at a Spanish referral center Eusebio García-Izquierdo Jaén,a Juan Francisco Oteo Domínguez,a,* Marta Jiménez Blanco,a Cristina Aguilera Agudo,a Fernando Domínguez,a Jorge Toquero Ramos,a Javier Segovia Cubero,a Clara Salas Antón,b Arturo García-Touchard,a José Antonio Fernández-Díaz,a Rodrigo Estévez-Loureiro,a Francisco Javier Goicolea Ruigómez,a and Luis Alonso-Pulpóna a Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain b Servicio de Anatomía Patológica, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain ABSTRACT Introduction and objectives: Endomyocardial biopsy (EMB) is an established diagnostic tool in myocardial disease. However, this technique may carry major complications. We present the diagnostic and safety results of our experience in EMB in the non-trans- plant setting. We also present the results after the implementation of a technical and safety protocol developed at our center. Methods: We retrospectively analyzed the data of all EMBs conducted in non-transplant patients from September 2004 through July 2018. We compared the diagnostic yield and rate of major complications of EMB in two different periods: before and after implementing the protocol. Results: We included 204 EMBs performed in 190 patients. The most frequent indications were the evaluation of ventricular dys- function or suspected myocarditis (51.5%) and the evaluation of restrictive cardiomyopathy or suspected infiltrative disease (44.6%). One hundred and seventy-two EMBs were performed in the right cardiac chambers (84.3%) and 30 EMBs in the left cardiac chambers (14.7%).